Advertisement
Screener

CITADEL ADVISORS LLC Historic Quarter Change: USA Options, Added, 2016 Q4, Page 16

CITADEL ADVISORS LLC historic quarter change: USA Options, Added

In put and call options, at their filed underlying value (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 48,961 positions, added to 115,287, reduced 112,564 and sold out of 46,247.

  • Q4 2016: Stock SGMO; Country of operation United States; Class Cmn · Put; Shares before 36,400.
  • Q4 2016: Stock MUSA; Country of operation United States; Class Cmn · Call; Shares before 5,300.
  • Q4 2016: Stock PEREGRINE PHARMACEUTICALS IN; Country of operation —; Class Cmn · Call; Shares before 13,900.
  • Q4 2016: Stock QEP RES INC; Country of operation —; Class Cmn · Call; Shares before 49,700.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2016SGMO
SANGAMO BIOSCIENCES INC
United StatesCmn · Put36,40056,300+19,900$169$172+$32017-02-10
Q4 2016MUSA
MURPHY USA INC
United StatesCmn · Call5,3006,100+800$378$375-$32017-02-10
Q4 2016PEREGRINE PHARMACEUTICALS IN
CUSIP 713661304
Cmn · Call13,90028,500+14,600$6$9+$32017-02-10
Q4 2016QEP RES INC
CUSIP 74733V100
Cmn · Call49,70052,900+3,200$971$974+$32017-02-10
Q4 2016MVIS
MICROVISION INC DEL
United StatesCmn · Call26,70027,200+500$37$34-$32017-02-10
Q4 2016UPBD
RENT A CTR INC NEW
United StatesCmn · Call18,20020,700+2,500$230$233+$32017-02-10
Q4 2016LIBERTY GLOBAL PLC
CUSIP G5480U120
Cmn · Call6,3006,900+600$208$205-$32017-02-10
Q4 2016OCH ZIFF CAP MGMT GROUP
CUSIP 67551U105
Cmn · Put18,60023,500+4,900$81$78-$32017-02-10
Q4 2016WPC
W P CAREY INC
United StatesCmn · Put8,4009,200+800$542$544+$22017-02-10
Q4 2016CARLYLE GROUP L P
CUSIP 14309L102
Cmn · Call14,20014,600+400$221$223+$22017-02-10
Q4 2016RL
RALPH LAUREN CORP
United StatesCmn · Call76,60085,800+9,200$7,747$7,749+$22017-02-10
Q4 2016ALCOBRA LTD
CUSIP M2239P109
Cmn · Call12,10013,100+1,000$30$28-$22017-02-10
Q4 2016INTREXON CORP
CUSIP 46122T102
Cmn · Put52,70060,700+8,000$1,477$1,475-$22017-02-10
Q4 2016VIACOM INC NEW
CUSIP 92553P102
Cmn · Put6,1006,800+700$261$262+$12017-02-10
Q4 2016MFIN
MEDALLION FINL CORP
United StatesCmn · Call35,60049,200+13,600$150$149-$12017-02-10
Q4 2016BELLICUM PHARMACEUTICALS INC
CUSIP 079481107
Cmn · Call13,50019,800+6,300$269$270+$12017-02-10
Q4 2016PORTOLA PHARMACEUTICALS INC
CUSIP 737010108
Cmn · Call21,90022,100+200$497$496-$12017-02-10
Q4 2016TUR
ISHARES
United StatesCmn · Put49,50057,700+8,200$1,874$1,874$02017-02-10
Q4 2016DOMINION DIAMOND CORP
CUSIP 257287102
Cmn · Call11,80011,900+100$115$115$02017-02-10
Q4 2016FHI
FEDERATED INVS INC PA
United StatesCmn · Call6,9007,200+300$204$204$02017-02-10

Similar Firms

Firm NameCountry13F ValueHoldings
Capital Research Global InvestorsUnited States$644.560B459
Invesco Ltd.United States$653.294B23,552
CHARLES SCHWAB INVESTMENT MANAGEMENT INCUnited States$654.473B3,645
UBS Group AGSwitzerland$666.317B22,771
ROYAL BANK OF CANADACanada$570.144B25,608
Bank of New York Mellon CorpUnited States$543.906B33,728
WELLINGTON MANAGEMENT GROUP LLPUnited States$535.463B7,458
WELLS FARGO & COMPANY/MNUnited States$530.336B17,971
Capital World InvestorsUnited States$732.940B620
DIMENSIONAL FUND ADVISORS LPUnited States$481.393B13,635